C. Brock

2.3k total citations · 1 hit paper
33 papers, 1.8k citations indexed

About

C. Brock is a scholar working on Cancer Research, Molecular Biology and Genetics. According to data from OpenAlex, C. Brock has authored 33 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 8 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in C. Brock's work include Glioma Diagnosis and Treatment (8 papers), Medical Imaging Techniques and Applications (6 papers) and Cancer Genomics and Diagnostics (5 papers). C. Brock is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Medical Imaging Techniques and Applications (6 papers) and Cancer Genomics and Diagnostics (5 papers). C. Brock collaborates with scholars based in United Kingdom, United States and Australia. C. Brock's co-authors include E.S. Newlands, Stephen R. Wedge, M. F. G. STEVENS, Richard T. Wheelhouse, Mark Bower, Gordon Rustin, Helen Evans, M.G. Glaser, L. Holden and Iain Colquhoun and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

C. Brock

31 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

1997 631 citations E.S. Newlands, M. F. G. STEVENS et al. Cancer Treatment Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Brock United Kingdom	15	656	572	431	347	297	33	1.8k
Wim van Putten Netherlands	16	727 1.1×	1.4k 2.4×	399 0.9×	603 1.7×	266 0.9×	26	3.4k
April F. Eichler United States	20	1.0k 1.5×	689 1.2×	1.2k 2.8×	1.1k 3.1×	243 0.8×	33	2.7k
R. Rampling United Kingdom	19	1.3k 2.0×	565 1.0×	681 1.6×	500 1.4×	230 0.8×	30	2.1k
P. Koch Germany	23	393 0.6×	303 0.5×	776 1.8×	905 2.6×	196 0.7×	67	3.1k
Markus Hutterer Austria	17	923 1.4×	271 0.5×	370 0.9×	360 1.0×	722 2.4×	47	1.6k
Daniel Williamson United Kingdom	24	518 0.8×	1.1k 2.0×	249 0.6×	238 0.7×	70 0.2×	60	1.9k
Wendy Seiferheld United States	18	1.1k 1.6×	167 0.3×	781 1.8×	229 0.7×	216 0.7×	32	1.8k
Kami J. Maddocks United States	30	1.8k 2.8×	813 1.4×	321 0.7×	1.5k 4.4×	248 0.8×	197	3.7k
Rushdia Z. Yusuf United States	14	345 0.5×	1.1k 2.0×	146 0.3×	418 1.2×	91 0.3×	26	2.3k
Judith Ochs United States	20	349 0.5×	619 1.1×	2.0k 4.6×	1.8k 5.3×	210 0.7×	32	3.3k

Countries citing papers authored by C. Brock

Since Specialization

Citations

This map shows the geographic impact of C. Brock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Brock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Brock more than expected).

Fields of papers citing papers by C. Brock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Brock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Brock. The network helps show where C. Brock may publish in the future.

Co-authorship network of co-authors of C. Brock

This figure shows the co-authorship network connecting the top 25 collaborators of C. Brock. A scholar is included among the top collaborators of C. Brock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Brock. C. Brock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Golden, Lesley R., Shemeka Thorpe, C. Brock, et al.. (2025). Microglia-derived APOE2 improves remyelination even in the presence of endogenous APOE4. Journal of Neuroinflammation. 23(1). 18–18.

Fadel, Michael G, et al.. (2022). Splenogonadal fusion: aiding detection and avoiding radical orchidectomy.. PubMed. 104(2). 32–34. 2 indexed citations

Nathan, Paul, David Chao, C. Brock, et al.. (2006). The place of VEGF inhibition in the current management of renal cell carcinoma. British Journal of Cancer. 94(9). 1217–1220. 16 indexed citations

Pacey, Simon, Daniel Rea, Neil Steven, et al.. (2004). Results of a phase 1 clinical trial investigating a combination of the oral mTOR-inhibitor Everolimus (E, RAD001) and Gemcitabine (GEM) in patients (pts) with advanced cancers. Journal of Clinical Oncology. 22(14_suppl). 3120–3120. 10 indexed citations

Jonge, Maja J.A. de, Stan B. Kaye, Jaap Verweij, et al.. (2004). Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1–5 of a 3-weekly cycle in patients with advanced solid tumours. British Journal of Cancer. 91(8). 1459–1465. 15 indexed citations

Waldman, Adam, Jeremy Rees, C. Brock, et al.. (2003). MRI of the brain with ultra-short echo-time pulse sequences. Neuroradiology. 45(12). 887–892. 76 indexed citations

Brock, C. & Siow Ming Lee. (2002). Anti-angiogenic strategies and vascular targeting in the treatment of lung cancer. European Respiratory Journal. 19(3). 557–570. 23 indexed citations

Brock, C.. (2002). Targeted Molecular Imaging in Oncology. British Journal of Cancer. 86(9). 1528–1528. 1 indexed citations

Power, David A., Richard S. Brown, C. Brock, et al.. (2001). Trends in testicular carcinoma in England and Wales, 1971–99. British Journal of Urology. 87(4). 361–365. 60 indexed citations

10.

Brock, C., Jarosław B. Ćwikła, Pauline Leonard, et al.. (2000). Does technetium-99m sestamibi (MIBI) scintimammography predict breast tumour response to anthracycline-based chemotherapy?. UCL Discovery (University College London). 1 indexed citations

11.

Brock, C., Helen Young, S.M. O'Reilly, et al.. (2000). Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography:a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas. British Journal of Cancer. 82(3). 608–615. 86 indexed citations

12.

Balesaria, Sara, C. Brock, Mark Bower, et al.. (1999). Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas. British Journal of Cancer. 81(8). 1371–1377. 54 indexed citations

13.

Brock, C., E.S. Newlands, Stephen R. Wedge, et al.. (1998). Phase I trial of temozolomide using an extended continuous oral schedule.. PubMed. 58(19). 4363–7. 228 indexed citations

14.

Newlands, E.S., Mark Bower, L. Holden, et al.. (1998). The management of high‐risk gestational trophoblastic tumours (GTT). International Journal of Gynecology & Obstetrics. 60(S1). S65–70. 21 indexed citations

15.

Newlands, E.S., M. F. G. STEVENS, Stephen R. Wedge, Richard T. Wheelhouse, & C. Brock. (1997). Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treatment Reviews. 23(1). 35–61. 631 indexed citations breakdown →

16.

Brock, C. & Mark Bower. (1997). Current perspectives in gliomas. Medical Oncology. 14(2). 103–120. 12 indexed citations

17.

Bower, Mark, C. Brock, L. Holden, et al.. (1997). POMB/ACE chemotherapy for mediastinal germ cell tumours. European Journal of Cancer. 33(6). 838–842. 7 indexed citations

18.

Bower, Mark, E.S. Newlands, L. Holden, et al.. (1997). EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.. Journal of Clinical Oncology. 15(7). 2636–2643. 231 indexed citations

19.

Newlands, E.S., S.M. O'Reilly, M.G. Glaser, et al.. (1996). The charing cross hospital experience with temozolomide in patients with gliomas. European Journal of Cancer. 32(13). 2236–2241. 122 indexed citations

20.

Bower, Mark, C. Brock, Rosemary A. Fisher, E.S. Newlands, & G.J.S. Rustin. (1995). Gestational choriocarcinoma. Annals of Oncology. 6(5). 503–508. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact